 | • レポートコード：MRC23Q35973 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界の塞栓療法製品市場について調査・分析し、世界の塞栓療法製品市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（塞栓ミクロスフェア、塞栓粒子、塞栓コイル、液体塞栓剤、塞栓補助材料、その他）、用途別セグメント分析（腫瘍、末梢血管疾患（PVD）、神経学、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、Medtronic、Boston Scientific、Terumo、Penumbra、Johnson & Johnson、Grandpharma (Sirtex)、Merit Medical、Siemens Healthineers (Varian)、Stryker、Jiangsu Hengrui Medicine、Cook Medical、Kaneka、Meril Life Sciences、Peijia Medical、Wallaby Medical、MicroPort Scientific Corporation、Weihai Visee Medical Devices、Beijing Taijieweiye Technologyなどが含まれています。世界の塞栓療法製品市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、塞栓療法製品市場規模を推定する際に考慮しました。本レポートは、塞栓療法製品の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、塞栓療法製品に関するビジネス上の意思決定に役立てることを目的としています。 ・塞栓療法製品市場の概要 - 塞栓療法製品のタイプ別セグメント - 世界の塞栓療法製品市場規模：タイプ別分析（塞栓ミクロスフェア、塞栓粒子、塞栓コイル、液体塞栓剤、塞栓補助材料、その他） - 塞栓療法製品の用途別セグメント - 世界の塞栓療法製品市場規模：用途別分析（腫瘍、末梢血管疾患（PVD）、神経学、その他） - 世界の塞栓療法製品市場規模予測（2018年-2029年） ・塞栓療法製品市場の成長トレンド - 塞栓療法製品の地域別市場規模（2018年-2029年） - 塞栓療法製品市場ダイナミクス - 塞栓療法製品の業界動向 - 塞栓療法製品市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：塞栓ミクロスフェア、塞栓粒子、塞栓コイル、液体塞栓剤、塞栓補助材料、その他 - 世界の塞栓療法製品のタイプ別市場規模（2018年-2023年） - 世界の塞栓療法製品のタイプ別市場規模（2024年-2029年） ・用途別セグメント：腫瘍、末梢血管疾患（PVD）、神経学、その他 - 世界の塞栓療法製品の用途別市場規模（2018年-2023年） - 世界の塞栓療法製品の用途別市場規模（2024年-2029年） ・塞栓療法製品の地域別市場規模 - 北米の塞栓療法製品市場規模（2018年-2029年） - アメリカの塞栓療法製品市場規模（2018年-2029年） - ヨーロッパの塞栓療法製品市場規模（2018年-2029年） - アジア太平洋の塞栓療法製品市場規模（2018年-2029年） - 中国の塞栓療法製品市場規模（2018年-2029年） - 日本の塞栓療法製品市場規模（2018年-2029年） - 韓国の塞栓療法製品市場規模（2018年-2029年） - インドの塞栓療法製品市場規模（2018年-2029年） - オーストラリアの塞栓療法製品市場規模（2018年-2029年） - 中南米の塞栓療法製品市場規模（2018年-2029年） - 中東・アフリカの塞栓療法製品市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 Medtronic、Boston Scientific、Terumo、Penumbra、Johnson & Johnson、Grandpharma (Sirtex)、Merit Medical、Siemens Healthineers (Varian)、Stryker、Jiangsu Hengrui Medicine、Cook Medical、Kaneka、Meril Life Sciences、Peijia Medical、Wallaby Medical、MicroPort Scientific Corporation、Weihai Visee Medical Devices、Beijing Taijieweiye Technology ・アナリストの観点/結論 ・調査方法とデータソース |
Playing a more vital role in the field of medicine than ever before, embolotherapy is a type of endovascular treatment that aims to occlude abnormal blood vessels in order to control bleeding, close fistulae or arteriovenous malformations, devascularise organs, reduce tumours and much more.
Highlights
The global Embolotherapy Product market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Embolotherapy Product is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Embolotherapy Product is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Embolotherapy Product in Oncology is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Embolotherapy Product include Medtronic, Boston Scientific, Terumo, Penumbra, Johnson & Johnson, Grandpharma (Sirtex), Merit Medical, Siemens Healthineers (Varian) and Stryker, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Embolotherapy Product, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Embolotherapy Product.
The Embolotherapy Product market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Embolotherapy Product market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Embolotherapy Product companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Medtronic
Boston Scientific
Terumo
Penumbra
Johnson & Johnson
Grandpharma (Sirtex)
Merit Medical
Siemens Healthineers (Varian)
Stryker
Jiangsu Hengrui Medicine
Cook Medical
Kaneka
Meril Life Sciences
Peijia Medical
Wallaby Medical
MicroPort Scientific Corporation
Weihai Visee Medical Devices
Beijing Taijieweiye Technology
Segment by Type
Embolization Microspheres
Embolization Particles
Embolization Coil
Liquid Embolic Agents
Auxiliary Embolic Material
Others
Segment by Application
Oncology
Peripheral Vascular Disease (PVD)
Neurology
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Embolotherapy Product companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Embolotherapy Product Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Embolization Microspheres
1.2.3 Embolization Particles
1.2.4 Embolization Coil
1.2.5 Liquid Embolic Agents
1.2.6 Auxiliary Embolic Material
1.2.7 Others
1.3 Market by Application
1.3.1 Global Embolotherapy Product Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Peripheral Vascular Disease (PVD)
1.3.4 Neurology
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Embolotherapy Product Market Perspective (2018-2029)
2.2 Embolotherapy Product Growth Trends by Region
2.2.1 Global Embolotherapy Product Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Embolotherapy Product Historic Market Size by Region (2018-2023)
2.2.3 Embolotherapy Product Forecasted Market Size by Region (2024-2029)
2.3 Embolotherapy Product Market Dynamics
2.3.1 Embolotherapy Product Industry Trends
2.3.2 Embolotherapy Product Market Drivers
2.3.3 Embolotherapy Product Market Challenges
2.3.4 Embolotherapy Product Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Embolotherapy Product Players by Revenue
3.1.1 Global Top Embolotherapy Product Players by Revenue (2018-2023)
3.1.2 Global Embolotherapy Product Revenue Market Share by Players (2018-2023)
3.2 Global Embolotherapy Product Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Embolotherapy Product Revenue
3.4 Global Embolotherapy Product Market Concentration Ratio
3.4.1 Global Embolotherapy Product Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Embolotherapy Product Revenue in 2022
3.5 Embolotherapy Product Key Players Head office and Area Served
3.6 Key Players Embolotherapy Product Product Solution and Service
3.7 Date of Enter into Embolotherapy Product Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Embolotherapy Product Breakdown Data by Type
4.1 Global Embolotherapy Product Historic Market Size by Type (2018-2023)
4.2 Global Embolotherapy Product Forecasted Market Size by Type (2024-2029)
5 Embolotherapy Product Breakdown Data by Application
5.1 Global Embolotherapy Product Historic Market Size by Application (2018-2023)
5.2 Global Embolotherapy Product Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Embolotherapy Product Market Size (2018-2029)
6.2 North America Embolotherapy Product Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Embolotherapy Product Market Size by Country (2018-2023)
6.4 North America Embolotherapy Product Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Embolotherapy Product Market Size (2018-2029)
7.2 Europe Embolotherapy Product Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Embolotherapy Product Market Size by Country (2018-2023)
7.4 Europe Embolotherapy Product Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Embolotherapy Product Market Size (2018-2029)
8.2 Asia-Pacific Embolotherapy Product Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Embolotherapy Product Market Size by Region (2018-2023)
8.4 Asia-Pacific Embolotherapy Product Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Embolotherapy Product Market Size (2018-2029)
9.2 Latin America Embolotherapy Product Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Embolotherapy Product Market Size by Country (2018-2023)
9.4 Latin America Embolotherapy Product Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Embolotherapy Product Market Size (2018-2029)
10.2 Middle East & Africa Embolotherapy Product Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Embolotherapy Product Market Size by Country (2018-2023)
10.4 Middle East & Africa Embolotherapy Product Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medtronic
11.1.1 Medtronic Company Detail
11.1.2 Medtronic Business Overview
11.1.3 Medtronic Embolotherapy Product Introduction
11.1.4 Medtronic Revenue in Embolotherapy Product Business (2018-2023)
11.1.5 Medtronic Recent Development
11.2 Boston Scientific
11.2.1 Boston Scientific Company Detail
11.2.2 Boston Scientific Business Overview
11.2.3 Boston Scientific Embolotherapy Product Introduction
11.2.4 Boston Scientific Revenue in Embolotherapy Product Business (2018-2023)
11.2.5 Boston Scientific Recent Development
11.3 Terumo
11.3.1 Terumo Company Detail
11.3.2 Terumo Business Overview
11.3.3 Terumo Embolotherapy Product Introduction
11.3.4 Terumo Revenue in Embolotherapy Product Business (2018-2023)
11.3.5 Terumo Recent Development
11.4 Penumbra
11.4.1 Penumbra Company Detail
11.4.2 Penumbra Business Overview
11.4.3 Penumbra Embolotherapy Product Introduction
11.4.4 Penumbra Revenue in Embolotherapy Product Business (2018-2023)
11.4.5 Penumbra Recent Development
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Detail
11.5.2 Johnson & Johnson Business Overview
11.5.3 Johnson & Johnson Embolotherapy Product Introduction
11.5.4 Johnson & Johnson Revenue in Embolotherapy Product Business (2018-2023)
11.5.5 Johnson & Johnson Recent Development
11.6 Grandpharma (Sirtex)
11.6.1 Grandpharma (Sirtex) Company Detail
11.6.2 Grandpharma (Sirtex) Business Overview
11.6.3 Grandpharma (Sirtex) Embolotherapy Product Introduction
11.6.4 Grandpharma (Sirtex) Revenue in Embolotherapy Product Business (2018-2023)
11.6.5 Grandpharma (Sirtex) Recent Development
11.7 Merit Medical
11.7.1 Merit Medical Company Detail
11.7.2 Merit Medical Business Overview
11.7.3 Merit Medical Embolotherapy Product Introduction
11.7.4 Merit Medical Revenue in Embolotherapy Product Business (2018-2023)
11.7.5 Merit Medical Recent Development
11.8 Siemens Healthineers (Varian)
11.8.1 Siemens Healthineers (Varian) Company Detail
11.8.2 Siemens Healthineers (Varian) Business Overview
11.8.3 Siemens Healthineers (Varian) Embolotherapy Product Introduction
11.8.4 Siemens Healthineers (Varian) Revenue in Embolotherapy Product Business (2018-2023)
11.8.5 Siemens Healthineers (Varian) Recent Development
11.9 Stryker
11.9.1 Stryker Company Detail
11.9.2 Stryker Business Overview
11.9.3 Stryker Embolotherapy Product Introduction
11.9.4 Stryker Revenue in Embolotherapy Product Business (2018-2023)
11.9.5 Stryker Recent Development
11.10 Jiangsu Hengrui Medicine
11.10.1 Jiangsu Hengrui Medicine Company Detail
11.10.2 Jiangsu Hengrui Medicine Business Overview
11.10.3 Jiangsu Hengrui Medicine Embolotherapy Product Introduction
11.10.4 Jiangsu Hengrui Medicine Revenue in Embolotherapy Product Business (2018-2023)
11.10.5 Jiangsu Hengrui Medicine Recent Development
11.11 Cook Medical
11.11.1 Cook Medical Company Detail
11.11.2 Cook Medical Business Overview
11.11.3 Cook Medical Embolotherapy Product Introduction
11.11.4 Cook Medical Revenue in Embolotherapy Product Business (2018-2023)
11.11.5 Cook Medical Recent Development
11.12 Kaneka
11.12.1 Kaneka Company Detail
11.12.2 Kaneka Business Overview
11.12.3 Kaneka Embolotherapy Product Introduction
11.12.4 Kaneka Revenue in Embolotherapy Product Business (2018-2023)
11.12.5 Kaneka Recent Development
11.13 Meril Life Sciences
11.13.1 Meril Life Sciences Company Detail
11.13.2 Meril Life Sciences Business Overview
11.13.3 Meril Life Sciences Embolotherapy Product Introduction
11.13.4 Meril Life Sciences Revenue in Embolotherapy Product Business (2018-2023)
11.13.5 Meril Life Sciences Recent Development
11.14 Peijia Medical
11.14.1 Peijia Medical Company Detail
11.14.2 Peijia Medical Business Overview
11.14.3 Peijia Medical Embolotherapy Product Introduction
11.14.4 Peijia Medical Revenue in Embolotherapy Product Business (2018-2023)
11.14.5 Peijia Medical Recent Development
11.15 Wallaby Medical
11.15.1 Wallaby Medical Company Detail
11.15.2 Wallaby Medical Business Overview
11.15.3 Wallaby Medical Embolotherapy Product Introduction
11.15.4 Wallaby Medical Revenue in Embolotherapy Product Business (2018-2023)
11.15.5 Wallaby Medical Recent Development
11.16 MicroPort Scientific Corporation
11.16.1 MicroPort Scientific Corporation Company Detail
11.16.2 MicroPort Scientific Corporation Business Overview
11.16.3 MicroPort Scientific Corporation Embolotherapy Product Introduction
11.16.4 MicroPort Scientific Corporation Revenue in Embolotherapy Product Business (2018-2023)
11.16.5 MicroPort Scientific Corporation Recent Development
11.17 Weihai Visee Medical Devices
11.17.1 Weihai Visee Medical Devices Company Detail
11.17.2 Weihai Visee Medical Devices Business Overview
11.17.3 Weihai Visee Medical Devices Embolotherapy Product Introduction
11.17.4 Weihai Visee Medical Devices Revenue in Embolotherapy Product Business (2018-2023)
11.17.5 Weihai Visee Medical Devices Recent Development
11.18 Beijing Taijieweiye Technology
11.18.1 Beijing Taijieweiye Technology Company Detail
11.18.2 Beijing Taijieweiye Technology Business Overview
11.18.3 Beijing Taijieweiye Technology Embolotherapy Product Introduction
11.18.4 Beijing Taijieweiye Technology Revenue in Embolotherapy Product Business (2018-2023)
11.18.5 Beijing Taijieweiye Technology Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details